首页> 外文OA文献 >The two-component system, ArlRS, regulates agglutination and pathogenesis in Staphylococcus aureus
【2h】

The two-component system, ArlRS, regulates agglutination and pathogenesis in Staphylococcus aureus

机译:双组分系统arlRs调节金黄色葡萄球菌的凝集和发病机制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Staphylococcus aureus is defined by its ability to agglutinate during exposure to human blood plasma. Although agglutination has long correlated with disease severity, the function of agglutination during infection remains unclear. Increasing evidence suggests the mechanisms of agglutination are highly complex and poorly understood. The goal of this dissertation was to characterize the mechanisms required for S. aureus agglutination in vitro and determine how these factors contribute to pathogenesis.Chapter II focuses on the development of two in vitro agglutination assays, which allow the process to be measured quantitatively. Through these assays, we confirmed the major factors contributing to agglutination are human fibrinogen and the bacterial surface protein, ClfA. Productive interactions between these two factors are required for agglutination to proceed. Surprisingly, we also identified a novel regulatory system that significantly contributed to agglutination. Inactivation of the ArlRS two-component system (TCS) prevents agglutination in both of the developed assays.Studies in Chapter III focused on characterizing the mechanism by which ArlRS inhibits agglutination. To examine regulation, quantitative PCR identified the major output of the ArlRS system as the gene ebh. Surprisingly, transcript levels of known extracellular matrix (ECM) binding proteins did not change. Characterization of ebh indicated that overexpression in an arlRS mutant is the major factor responsible for preventing agglutination. Deletion of ebh restores the ability of the arlRS mutant to agglutinate in both gravity and flow-based agglutination assays. Fluorescence microscopy of clumps indicates wildtype cells bind and incorporate fluorescently labeled human fibrinogen (Fg) displaying co-localization with the clumps. Surprisingly, arlRS mutants also bound human Fg, but these interactions were not productive for clumping, suggesting successful agglutination is more complex than binding ECM proteins. These studies indicate that ArlRS regulates agglutination through a unique mechanism that depends on the surface protein Ebh.Studies in Chapter IV were performed to determine the role ArlRS played in pathogenesis. A rabbit model of infective endocarditis and sepsis was employed to assess ArlRS virulence because this model has been shown to require agglutination for disease progression. Mutants in arlRS displayed reduced virulence in the rabbit model of infective endocarditis, which correlated with the mutantu27s inability to form a vegetation of the heart valve. These studies provide further insight into the importance of S. aureus agglutination during infection and define a mechanism of regulation through a novel surface protein.
机译:金黄色葡萄球菌通过其暴露于人血浆中的能力凝集定义。尽管凝集长期与疾病严重程度相关,凝集的感染过程中的作用尚不清楚。越来越多的证据表明,凝集的机制非常复杂,知之甚少。本文的目标是表征金黄色葡萄球菌凝集体外所需的机制,并确定这些因素如何有助于pathogenesis.Chapter II着眼于两种体外凝集测定,其允许进行定量测量的过程的发展。通过这些分析,我们证实有助于凝集的主要因素是人纤维蛋白原和细菌表面的蛋白质,ClfA。这两个因素之间的相互作用生产所需的凝集继续进行。出人意料的是,我们还确定了显著贡献凝集一种新型监管体系。所述ArlRS的失活的双组分系统(TCS)防止在无论是在第三章发达assays.Studies的凝集集中于表征由该ArlRS抑制凝集的机制。为了检验监管,定量PCR鉴定ArlRS系统的主要输出作为基因EBH。出人意料的是,已知的细胞外基质(ECM)结合蛋白的转录水平没有变化。 EBH的表征表明在arlRS突变是负责阻止凝集的主要因素是过度表达。 EBH的缺失突变体恢复在重力和基于流-凝集测定凝集的arlRS的能力。团块的荧光显微镜表明野生型细胞结合和掺入荧光标记的人纤维蛋白原(FG)显示共定位与团块。出人意料的是,arlRS突变体也结合人纤维蛋白原,但这些相互作用不是生产力的聚集,提示成功凝集比结合ECM蛋白更加复杂。这些研究表明,ArlRS凝集的调节作用,通过进行,以确定在发病中的作用ArlRS取决于在第四章表面蛋白Ebh.Studies的独特机制。感染性心内膜炎和败血症的兔模型,用于评估ArlRS毒力,因为该模型已经显示出需要用于疾病进展凝集。在arlRS突变体感染性心内膜炎的兔模型,其与突变体 u27s不能形成所述心脏瓣膜的植被相关显示的毒力降低。这些研究提供了进一步的深入了解金黄色葡萄球菌凝集的感染过程中的重要性,并通过一种新颖的表面蛋白限定调节的机构。

著录项

  • 作者

    Jennifer Nicole Walker;

  • 作者单位
  • 年度 -1
  • 总页数
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号